Search
Esperion Therapeutics Inc
ESPRAdd to Watchlist
3.150USD
-0.010-0.32%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
811.73MMarket Cap
LossP/E TTM
Esperion Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
403.13M
21.31%
EPS(YoY)
-0.11
60.53%
Analyst Rating
HOLD
2026-06-24
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its total revenue reached 403.13M, with a year-on-year change of 21.31.
What are the current assets of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its current assets were 462.57M, with a year-on-year change of 36.86.
What are the total assets of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its total assets of Esperion Therapeutics Inc were 465.89M, with a year-on-year change of 35.50.
What are the total liabilities of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its total liabilities of Esperion Therapeutics Inc were 767.85M, with a year-on-year change of 4.82.
What is the total equity of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its total equity of Esperion Therapeutics Inc was -301.96M, with a year-on-year change of 22.32.
What is the net financing of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its net financing of Esperion Therapeutics Inc was 36.18M, with a year-on-year change of -58.16.
What is the Earnings Per Share (EPS) of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.11, with a year-on-year change of 60.53.
What is the net margin of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its net profit margin was -5.63, with a year-on-year change of 63.87.
What is the gross margin of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its gross margin was 67.95, with a year-on-year change of -14.38.
What is the debt-to-asset ratio of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 117.03, with a year-on-year change of -31.32.
What is the Return on Assets (ROA) of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -5.60, with a year-on-year change of 70.25.
What is the operating profit of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2025 earnings report, its operating profit was 60.27M, with a year-on-year change of 10.79.
